BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12126634)

  • 1. Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis.
    Flynn JC; Wan Q; Panos JC; McCormick DJ; Giraldo AA; David CS; Kong YC
    J Autoimmun; 2002 May; 18(3):213-20. PubMed ID: 12126634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible.
    Wan Q; Shah R; Panos JC; Giraldo AA; David CS; Kong Yc
    Hum Immunol; 2002 Apr; 63(4):301-10. PubMed ID: 12039412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.
    Flynn JC; Meroueh C; Snower DP; David CS; Kong YM
    Clin Exp Immunol; 2007 Mar; 147(3):547-54. PubMed ID: 17302906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice.
    Flynn JC; Fuller BE; Giraldo AA; Panos JC; David CS; Kong YC
    J Autoimmun; 2001 Aug; 17(1):7-15. PubMed ID: 11488633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis.
    Kong YM; David CS; Lomo LC; Fuller BE; Motte RW; Giraldo AA
    Immunogenetics; 1997; 46(4):312-7. PubMed ID: 9218533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease.
    Kong YC; Flynn JC; Wan Q; David CS
    Autoimmunity; 2003; 36(6-7):397-404. PubMed ID: 14669947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models.
    Kong YC; David CS
    Int Rev Immunol; 2000; 19(6):573-85. PubMed ID: 11129116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice.
    Flynn JC; Gardas A; Wan Q; Gora M; Alsharabi G; Wei WZ; Giraldo AA; David CS; Kong YM; Banga JP
    Clin Exp Immunol; 2004 Sep; 137(3):503-12. PubMed ID: 15320899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis.
    Das P; Drescher KM; Geluk A; Bradley DS; Rodriguez M; David CS
    Hum Immunol; 2000 Mar; 61(3):279-89. PubMed ID: 10689117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.
    Mangalam A; Luckey D; Basal E; Jackson M; Smart M; Rodriguez M; David C
    J Immunol; 2009 Apr; 182(8):5131-9. PubMed ID: 19342694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of HLA class II transgenic mice to study autoimmune regulation.
    Kong YC; Flynn JC; Banga JP; David CS
    Thyroid; 2007 Oct; 17(10):995-1003. PubMed ID: 17900224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene.
    Kong YC; Lomo LC; Motte RW; Giraldo AA; Baisch J; Strauss G; Hämmerling GJ; David CS
    J Exp Med; 1996 Sep; 184(3):1167-72. PubMed ID: 9064334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis Phenotype.
    Shahi SK; Ali S; Jaime CM; Guseva NV; Mangalam AK
    Immunohorizons; 2021 Aug; 5(8):627-646. PubMed ID: 34380664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.
    Kong YC; Brown NK; Flynn JC; McCormick DJ; Brusic V; Morris GP; David CS
    J Autoimmun; 2011 Sep; 37(2):63-70. PubMed ID: 21683551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2-E transgenic class II-negative mice can distinguish self from nonself in susceptibility to heterologous thyroglobulins in autoimmune thyroiditis.
    Wan Q; Shah R; McCormick DJ; Lomo LC; Giraldo AA; David CS; Kong YM
    Immunogenetics; 1999 Oct; 50(1-2):22-30. PubMed ID: 10541803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tg.2098 is a major human thyroglobulin T-cell epitope.
    Menconi F; Huber A; Osman R; Concepcion E; Jacobson EM; Stefan M; David CS; Tomer Y
    J Autoimmun; 2010 Aug; 35(1):45-51. PubMed ID: 20303712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II.
    Kudva YC; Rajagopalan G; Raju R; Abraham RS; Smart M; Hanson J; David CS
    Hum Immunol; 2002 Nov; 63(11):987-99. PubMed ID: 12392851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.
    Abraham RS; Wen L; Marietta EV; David CS
    J Immunol; 2001 Jan; 166(2):1370-9. PubMed ID: 11145722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
    Abraham RS; Kudva YC; Wilson SB; Strominger JL; David CS
    Diabetes; 2000 Apr; 49(4):548-54. PubMed ID: 10871191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice.
    Karras E; Yang H; Lymberi P; Christadoss P
    J Autoimmun; 2005 Jun; 24(4):291-6. PubMed ID: 15927791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.